Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 8:14am ET

MRK Coverage

Page 27
10:20am ET
Health and Healthcare

How Keytruda Saved Merck’s Q1

Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.

MRK
Chris Lange
10:05am ET
Health and Healthcare

Merck Moves Ahead With Late-Stage Trial Win

Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.

MRK
Chris Lange
10:05am ET
Health and Healthcare

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well.

Chris Lange